title: Predictive factors for the benefit of perioperative FOLFOX for resectable liver metastasis in colorectal cancer patients (EORTC Intergroup Trial 40983).
authors.affiliation: Department of Digestive Surgery Department of Digestive Oncology Department of Digestive Surgery Rouen University Hospital Rouen, France michel.scotte@chu-rouen.fr.
authors.forename: Lilian
authors.initials: L
authors.lastname: Schwarz
authors.forename: Pierre
authors.initials: P
authors.lastname: Michel
authors.forename: Michel
authors.initials: M
authors.lastname: Scotté
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D015179:Colorectal Neoplasms / Q000473:pathology*; D005260:Female; D006801:Humans; D008113:Liver Neoplasms / Q000188:drug therapy* / Q000556:secondary*; D008297:Male; D019990:Perioperative Care